Abeona Therapeutics Inc.
ABEO · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $23 | $14 | $14 | $33 |
| Short-Term Investments | $74 | $38 | $38 | $12 |
| Receivables | $2 | $2 | $0 | $3 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $1 | $1 | $1 | $8 |
| Total Curr. Assets | $101 | $56 | $53 | $56 |
| Property Plant & Equip (Net) | $8 | $8 | $11 | $22 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $1 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $0 |
| Total NC Assets | $8 | $8 | $11 | $23 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $109 | $64 | $64 | $80 |
| Liabilities | – | – | – | – |
| Payables | $3 | $2 | $2 | $4 |
| Short-Term Debt | $7 | $1 | $2 | $2 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $6 | $11 | $4 | $10 |
| Total Curr. Liab. | $17 | $13 | $8 | $17 |
| LT Debt | $16 | $4 | $6 | $8 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $32 | $31 | $24 | $13 |
| Total NC Liab. | $48 | $36 | $30 | $21 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $4 | $5 | $8 | $9 |
| Total Liabilities | $65 | $49 | $37 | $37 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $1 |
| Retained Earnings | -$813 | -$750 | -$695 | -$656 |
| AOCI | $0 | -$0 | -$0 | -$0 |
| Other Equity | $857 | $764 | $722 | $697 |
| Total Equity | $44 | $15 | $27 | $42 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $109 | $64 | $64 | $80 |
| Net Debt | -$0 | -$9 | -$7 | -$24 |